187 related articles for article (PubMed ID: 33375719)
1. Upregulation of CD109 Promotes the Epithelial-to-Mesenchymal Transition and Stemness Properties of Lung Adenocarcinomas via Activation of the Hippo-YAP Signaling.
Lee KY; Kuo TC; Chou CM; Hsu WJ; Lee WC; Dai JZ; Wu SM; Lin CW
Cells; 2020 Dec; 10(1):. PubMed ID: 33375719
[TBL] [Abstract][Full Text] [Related]
2. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
Lee KY; Shueng PW; Chou CM; Lin BX; Lin MH; Kuo DY; Tsai IL; Wu SM; Lin CW
Cancer Sci; 2020 May; 111(5):1652-1662. PubMed ID: 32133706
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
4. Elevation of YAP promotes the epithelial-mesenchymal transition and tumor aggressiveness in colorectal cancer.
Ling HH; Kuo CC; Lin BX; Huang YH; Lin CW
Exp Cell Res; 2017 Jan; 350(1):218-225. PubMed ID: 27914787
[TBL] [Abstract][Full Text] [Related]
5. Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1α to drive lung adenocarcinoma metastasis.
Jan YH; Lai TC; Yang CJ; Lin YF; Huang MS; Hsiao M
J Hematol Oncol; 2019 Jan; 12(1):12. PubMed ID: 30696468
[TBL] [Abstract][Full Text] [Related]
6. CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF-β signaling.
Taki T; Shiraki Y; Enomoto A; Weng L; Chen C; Asai N; Murakumo Y; Yokoi K; Takahashi M; Mii S
Cancer Sci; 2020 Dec; 111(12):4616-4628. PubMed ID: 33007133
[TBL] [Abstract][Full Text] [Related]
7. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
[TBL] [Abstract][Full Text] [Related]
8. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R
Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399
[TBL] [Abstract][Full Text] [Related]
9. Stearoyl-CoA-desaturase-1 regulates gastric cancer stem-like properties and promotes tumour metastasis via Hippo/YAP pathway.
Gao Y; Li J; Xi H; Cui J; Zhang K; Zhang J; Zhang Y; Xu W; Liang W; Zhuang Z; Wang P; Qiao Z; Wei B; Chen L
Br J Cancer; 2020 Jun; 122(12):1837-1847. PubMed ID: 32350414
[TBL] [Abstract][Full Text] [Related]
10. YAP mediates the positive regulation of hnRNPK on the lung adenocarcinoma H1299 cell growth.
Xu L; Zhang T; Huang W; Liu X; Lu J; Gao X; Zhang YF; Liu L
Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):677-687. PubMed ID: 31187136
[TBL] [Abstract][Full Text] [Related]
11. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro.
Zhou S; da Silva SD; Siegel PM; Philip A
Sci Rep; 2019 Nov; 9(1):16317. PubMed ID: 31695056
[TBL] [Abstract][Full Text] [Related]
12. CD109 identified in circulating proteomics mitigates postoperative recurrence in chronic rhinosinusitis with nasal polyps by suppressing TGF-β1-induced epithelial-mesenchymal transition.
Gao R; Chen Y; Liu H; Ye M; Chu L; Wang T
Int Immunopharmacol; 2024 Mar; 130():111793. PubMed ID: 38442581
[TBL] [Abstract][Full Text] [Related]
13. SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC.
Zhang F; Lin H; Gu A; Li J; Liu L; Yu T; Cui Y; Deng W; Yan M; Li J; Yao M
J Proteomics; 2014 May; 102():125-36. PubMed ID: 24667143
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of FYN suppresses the epithelial-to-mesenchymal transition through down-regulating PI3K/AKT pathway in lung adenocarcinoma.
Xue F; Jia Y; Zhao J
Surg Oncol; 2020 Jun; 33():108-117. PubMed ID: 32561075
[TBL] [Abstract][Full Text] [Related]
15. A Ca
Dang DK; Makena MR; Llongueras JP; Prasad H; Ko M; Bandral M; Rao R
Mol Cancer Res; 2019 Aug; 17(8):1735-1747. PubMed ID: 31076498
[TBL] [Abstract][Full Text] [Related]
16. Furin promotes epithelial-mesenchymal transition in pancreatic cancer cells via Hippo-YAP pathway.
Zhang Y; Zhou M; Wei H; Zhou H; He J; Lu Y; Wang D; Chen B; Zeng J; Peng W; Du F; Gong A; Xu M
Int J Oncol; 2017 Apr; 50(4):1352-1362. PubMed ID: 28259973
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.
Salah Z; Itzhaki E; Aqeilan RI
Oncotarget; 2014 Nov; 5(21):10886-900. PubMed ID: 25350971
[TBL] [Abstract][Full Text] [Related]
18. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
19. Linc-RoR promotes proliferation, migration, and invasion via the Hippo/YAP pathway in pancreatic cancer cells.
Chen W; Wang H; Liu Y; Xu W; Ling C; Li Y; Liu J; Chen M; Zhang Y; Chen B; Gong A; Xu M
J Cell Biochem; 2020 Jan; 121(1):632-641. PubMed ID: 31452251
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways.
Karvonen H; Barker H; Kaleva L; Niininen W; Ungureanu D
Cells; 2019 Aug; 8(8):. PubMed ID: 31382410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]